Evidence map›Paper›PMID 27404392›Full record

ArticleScientific reports2016

Analyzing the CDR3 Repertoire with respect to TCR-Beta Chain V-D-J and V-J Rearrangements in Peripheral T Cells using HTS.

Long Ma, Liwen Yang, Bin Shi, Xiaoyan He, Aihua Peng, Yuehong Li, Teng Zhang, Suhong Sun, Rui Ma, Xinsheng Yao

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Article
  10. Two Step Selection for Bias inFrontiers in immunology · 2022
    Article
  11. TCRβ rearrangements without a D segment are common, abundant, and public.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Analysis of the Heterogeneity of CD4Journal of immunology research · 2020
    Article
  17. Replacement of TCR Dβ With Immunoglobulin DFrontiers in immunology · 2020
    Article
  18. Heterogeneity of CD4Frontiers in cell and developmental biology · 2020
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Long MaDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Liwen YangDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Bin ShiDepartment of Laboratory Medicine, Zunyi Medical University, Zunyi 563003, China.
Xiaoyan HeDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Aihua PengDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Yuehong LiDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Teng ZhangDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Suhong SunDepartment of Breast Surgery, The first Affiliated Hospital of Zunyi Medical University, Zunyi 563003, China.
Rui MaDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Xinsheng YaoDepartment of Immunology, Research Center for Medicine &Biology, Innovation &Practice Base for Graduate Students Education, Zunyi Medical University, Zunyi 563003, China.
Zunyi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

V-D-J rearrangement of the TCR-beta chain follows the 12/23 rule and the beyond 12/23 restriction. Currently, the proportion and characteristics of TCR-beta chain V-J rearrangement is unclear. We used high-throughput sequencing to compare and analyze TCR-beta chain V-J rearrangement and V-D-J rearrangement in the CDR3 repertoires of T cells from the PBMCs of six volunteers and six BALB/c mice. The results showed that the percentage of V-J rearrangement of the volunteers was approximately 0.7%, whereas that of the mice was 2.2%. The clonality of mice V-J rearrangement was significantly reduced compared with the V-D-J rearrangement, whereas the clonality of human V-J rearrangement was slightly reduced compared with the V-D-J rearrangement. V-J rearrangement in CDR3 involved the significant usage of N, S, F and L, whereas V-D-J rearrangement in CDR3 involved the significant usage of R and G. The levels of V deletion and J deletion in V-J rearrangement were significantly reduced compared with V-D-J rearrangement. TRBD and TRBJ usage in V-J rearrangement differed from that of V-D-J rearrangement, including dominant usage of TRBV and TRBJ and their pairing. Taken together, these results provide new ideas and technology for studies of V-D-J rearrangement and V-J rearrangement in the CDR3 repertoire.

Indexed as

AdultAnimalsFemaleHigh-Throughput Nucleotide SequencingHumansMaleMice, Inbred BALB CMiddle AgedPolymerase Chain ReactionReceptors, Antigen, T-Cell, alpha-betaT-LymphocytesYoung AdultReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID27404392
PMCPMC4941575
OpenAlexW2464476298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.